INTRODUCTION
There is a recognized need for the education of medical and paramedical staff for the prescription and delivery of oxvgen, a prescribable drug, to patients wAith chronic pulmonary disease and in particular cystic fibrosis (CF) . Lung disease progresses rapidly to death for the CF patient in the third to fourth decade of life, and the medical provision of oxygen is complex and difficult.
The prescription of oxygen for the treatment of hypoxaemia is well established but the practical application of the delivery of the gas is less well understood. Hypoxaemia, defined as a partial pressure of arterial oxygen (PaO2) below 55 mm Hg, induces an increase in cardiac output and pulmonarv vasoconstrictionl. These physiological responses increase PaO2, increase oxygen delivery and improve ventilation perfusion mismatching. However, the costs of these compensatory mechanisms are to increase the work of breathing, increase pulmonary artery pressure and increase the work of the heart. The use of supplemental oxygen reverses hypoxaemia, reduces the w%ork of breathing and the work of the heart. It is important to measure and optimize the response of the delivery of supplemental oxygen by careful attention to the monitoring of arterial or capillary blood gases (ABGs)2, the patient's respiratory rate and pulse. In practice, reversal of hypoxaemia, judged by blood gases, may be at the expense of the work of breathing. In chronic lung disease and CF, where the respiratory system is severely compromised, the consequences of this increased work can lead to muscle fatigue and respiratory failure3. The implication of the effect of this increase in the ork of breathing on unstable central airwvays and sputum retention in CF remains theoretical and the reversal by oxygen therapy requires further study. This article discusses what is known of the ventilator) response to hypercapnia and hypoxia in CF, the practical application of that knowrledge in oxygen delivery in the acute condition, the problems of providing adequate oxygen delivery for domiciliary care and the assessment and provision of oxygen during air and road travel. 6-20 years. In response to hypercapnia, the CF patient showed a blunted ventilatory response (measured by change in entilation (AVE) and tidal volume (AVT)) in the presence of normal neural drive. The neural drive is the pressure generated at the mouth in the first 100 msec of inspiration through an occluded mouthpiece and is known as the P0.1. This blunted ventilatory response can be attributed to impaired ventilatory mechanics and an abnormal respiratory load which increases the work of breathing.
Hypoxia
In the same study the responses to progressive hypoxia ( Figure 1 ) were initially supranormal for AVE, AVT and APO. 1, but at values below a PAO? of 50 mm Hg, there was a decrease in AVE and AVT in the presence of supranormal APO. I. The authors hypothesize that this abnormal response to severe hypoxia reflects the development of muscle fatigue. Although asthmatic and CF patients were matched for the degree of airways obstruction, there were differences in breathing patterns and drive to breathe. CF patients had a higher P0. 1 and AVE even at mild hypoxia. This is probably explained by stimulation of pulmonary stretch receptors, due to pulmonary fibrosis, increasing vagally mediated respiratory drive. CF patients showed a higher respiratory rate, reduced tidal volume and increased inspiratory time with more severe levels of hypoxia and hypercapnia. The authors suggest decreased lung compliance, resulting in a higher inspiratory load, as a possible explanation for the different breathing patterns. This paper demonstrates that CF patients are unlikely to retain C02 in response to oxygen above a PAO? of 50 Torr. However, below this level of hypoxia ventilation is reduced and respiratory failure easily develops. The breathing patterns adopted are indicative of respiratory muscular fatigue developing as a consequence of decreased oxygen supply and malnourished respiratory muscles. There is increasing evidence to suggest that there is a problem with both muscle quantity and quality in CF4 6 respiratory muscle strength are conflicting7'8 but patients who are malnourished may have reduced muscle strength9. Hyperinflation may reduce respiratory muscle efficiency10 and the important contribution of the abdominal muscles in response to hyperinflation in CF is described11. It is, therefore, imperative in CF that oxygen delivery is aimed at correcting hypoxia and minimizing any increase in the work of the respiratory muscles, otherwise respiratory failure will quickly ensue.
OXYGEN DELIVERY
Optimal oxygen delivery must consider three variables: (1) the source of the supply which has pressure and flow characteristics; (2) the delivery system, i.e. mask or nasal cannulae with flow and concentration characteristics; and (3) the demand for the oxygen i.e. the patient's peak inspiratory flow rate. Skilled manipulation and alteration of these variables will maximize the oxygen delivery to the patient but poor use and inadequate knowledge will adversely affect clinical outcome.
Oxygen source Oxygen is delivered by a piped system, cylinder, or concentrator. The piped source or cylinder gas passes through a pressure regulator to reduce the operating pressure to a safe level of 60 lb/in2 (PSI) . The flow rate is controlled by a manually operated needle valve which allows selection of a flow rate between I and 15 L/min 2. This oxygen is dry and cold. The natural mechanism of the dry gas under pressure is to adapt to the environmental humidity by removing moisture from the respiratory tract. It is well known that the respiratory secretions of CF are already dehydrated so every effort should be made to humidify dry gases to prevent sputum retention (vide infra). An oxygen concentrator operates at a much lower pressure, i.e. 8-13 PSI and flow is limited to 5 L/min. Concentrators can be used in parallel to increase the pressure and flow delivered. This oxygen is at room temperature and humidity.
Oxygen delivery devices There are three methods of oxygen delivery applicable to CF: (1) nasal cannulae which provide low concentrations at low flows; (2) fixed concentration masks which provide low to medium concentrations at high total gas flows; and (3) high flow generators to provide medium concentrations at high flows which are unachievable with a flow regulator of 15 L/min.
Nasal cannulae
Nasal cannulae deliver 100% oxygen which is diluted by the patient's peak inspiratory flow rate to provide an unknown concentration. The inspiratory flow rate will differ between patients and will vary within a patient. During episodes of breathlessness and exercise, the inspiratory flow rate will rise (we have seen increases of up to 200 L/min in our patients) and therefore reduce the concentration for a given flow rate. The patient's inspiratory flow rate will decrease during sleep13 and provide an increased concentration for a given delivered flow. This increased concentration may be sufficient to induce hypercapnia and respiratory failure. During sleep, CF patients may have significant falls in oxygen saturation due to hypoventilation and loss of activity of the diaphragm and intercostal muscles. Transcutaneous PCO2 monitoring has shown an average increase of 7 mmHg from daytime to sleep when breathing room air. This was further increased by 4 mmHg with the addition of 2 L of oxygenl3. Therefore, the use of nasal cannulae with an unknown concentration is not recommended for night use. The response to oxygen will also differ during an acute exacerbation from the stable state. Careful evaluation of oxygen delivery at night is recommended before prescription and precise instructions to the patient to report any changes in respiratory symptoms if long-term oxygen at home is prescribed. Day-time blood gases taken when the patient is at rest and awake do not reflect a 24-hour situation. The prescription of oxygen will therefore differ during the daytime at rest, during exercise and night-time. Prescription of oxygen via nasal cannulae should record flow rate only and give precise details for daytime, exercise and night-time usel. Typical values of 2 L of oxygen delivered by nasal cannulae equating to a concentration of 24% are misleading14. Bazuaye et a]. showed that the oxygen concentration varied between 24% and 35% when 2 L of oxygen were delivered to patients with chronic obstructive airways disease who were clinically stable, at rest and awake. There are both advantages and disadvantages of nasal cannulae. It is recognized that nasal cannulae are easy to use, relatively comfortable and preferred by patients15. They operate at low flows so are quiet and have the added advantage of allowing the patient to eat, drink and talk during operation. As discussed, the main disadvantage is that the oxygen concentration varies during use. It is suggested that mouth breathing does not influence oxygen delivery16 because oxygen is entrained in the nasopharynx. However, in that study the patients were clinically stable and at rest. The effect of the high flow rates generated during exercise and after coughing, on entrainment remain to be confirmed. It is our experience that patients prefer the high flow of a Venturi mask for the relief of breathlessness after exercise and bouts of coughing. It is our routine practice to prescribe a Venturi mask for chest clearance. If nasal cannulae are used the prescription of the appropriate adjustment to flow rate will be required.
Fixed concentration masks
Fixed concentration masks (Venturi masks) are designed to deliver an accurate concentration of oxygen irrespective of changes in patient's inspiratory flow rate. They function by the principle of jet mixing of oxygen and air to provide high total gas flows and were previously described as high airflow with oxygen enrichment masks (HAFOE). The total gas flow is determined by an air entrainment ratio which is specific to each oxygen concentration. Table 1 shows that increasing the oxygen flow rate increases the total gas supply to the patient without any increase in the oxygen concentration. A flow rate is often recommended for each concentration by the manufacturer of the masks, e.g. 2 L for 24%, 4 L 28%. This recommendation is aimed at a peak tidal inspiratory flow of 40-50 L/min. We have previously 32described that the peak tidal inspiratory flow will vary. These masks will deliver an accurate concentration, providing the total gas flow delivered by the mask is equal to or greater than the peak inspiratory flow rate ofthe patient17. When the inspiratory flow rate exceeds the delivery of the mask, room air is drawn into the mask, the oxygen concentration is diluted and the work of the respiratory muscles is increased. A more accurate recommendation by the manufacturers would be to adjust the flow rate to the patient's comfort.
Patients are quick to respond to an insufficient flow rate by describing a feeling of suffocation, discarding the mask and reporting oxygen therapy to increase the symptoms of dyspnoea. Unnecessary prescription of higher concentrations of oxygen or even mechanical ventilation may be avoided18 simply by increasing the flow rate to provide a higher total gas flow and match the patient's peak tidal inspiratory flow. Oxygenation will improve and the patient's breathing will feel more comfortable. Examples of increasing flow rate are shown in Table 2 . We have described an increase in respiratory drive (P0.1) in CF and since inspiratory flow is a crude measure of that drive13 it would suggest that CF patients have higher than normal flow rates. Currently, there is no objective measure of peak tidal inspiratory flow rate at the bedside. Adjusting the flow rate to the patient's comfort with careful explanation regarding the consequences of inadequate flow permits an accurate assessment. It is better to supply too high a flow than too low and reduce the oxygen concentration delivered. Other practical suggestions have been described; placing a tissue close to the holes of the mask will indicate any indrawing during inspiration18. In the future, a novel inspiratory flow meter (Clement Clarke, Harlow, England) may prove an invaluable tool in oxygen assessment. Su Oxygen concentrations most commonly used in CF are 24% and 28%. Flow rates of 100 L/min are easily achieved in the ward situation at these concentrations and in the majority of situations these flow rates are adequate for the treatment of an acute exacerbation. If a higher concentration is required to relieve hypoxia, a flow meter with a limit of 15 L/min is not sufficient to provide high total flows. In this situation a high flow generator would be considered to supply 32% oxygen with total flows of 130 L/min. However, operation of a high flow generator requires a piped oxygen supply ( Figure 2 ). In the acute situation, the delivery of oxygen via 24%, 28% masks or 32% via a high flow generator are recommended. This ensures relief of hypoxia without increasing hypercapnia and minimizes the sense of effort in the respiratory muscles. For 24% and 28%, prescription should include the concentration and flow rate. The high flow generator delivers a high flow rate irrespective of the oxygen concentration, so prescription should include the concentration and the term 'high flow'. Daytime and nighttime requirements will still vary with fixed concentration masks so the prescription should reflect any differences.
Monitoring the response of oxygen therapy Arterial or capillary blood gases reflect levels of oxygen and carbon dioxide in the blood and any metabolic compensations. Pulse oximetry has the advantage of being a noninvasive investigation which gives a quick measure of the oxygenation of arterial blood. In contrast to arterial blood gases it does not indicate carbon dioxide elimination, a measure of the adequacy of ventilation, so does not signal ventilatory failure19. If the patient is breathing supplemental oxygen rather than room air, pulse oximetry becomes less sensitive to hypoventilation. The PaO2 will be higher, so CO2 will have to rise still further before hypoxaemia sufficient to produce measurable desaturation occurs20. The accuracy of oximeter readings is subject to error. On the flat part of the oxygen dissociation curve this can represent large falls in PaO2; on the steep part of the curve the fall in PaO2 is less but clinically more significant21. Pulse oximetry has been shown to overestimate arterial saturation during hypoxaemia and exercise22. Other contributing factors to inaccuracy are pigmentation, finger clubbing, peripheral perfusion, nail varnish and pierced ears. Knowledge of the basic principles and interpretation of the results by medical and nursing staff is poor23. This form of monitoring can give a false sense of security in the acute exacerbation and it has been suggested that pulse oximetry should not be used to direct oxygen therapy in chronic obstructive airways disease24. An oxygen analyser is sensitive to delivered oxygen but takes no account of inspiratory flow rate and is not therefore an indication of oxygen received. Monitoring of blood gases with the appropriate prescription of oxygen to reverse hypoxaemia should be part of the routine management of CF, in the stable state, during an acute exacerbation, at night-time and during the day, and while awaiting transplantation25.
Side effects of oxygen Patients may report adverse effects of oxygen and blame the drug. Side effects include tightness, wheeze, shortness of breath and dryness. Oxygen delivered from a piped supply or cylinders is cold and dry. This may be sufficient to induce chest tightness and wheeze in those patients with hyperreactive airways. Any increase in the work of breathing due to inadequate flow rates, especially in patients with unstable central airways, can potentially cause tightness and shortness of breath. Gases delivered under pressure are dry and together with a high flow rate will dry the airway mucosa, decrease cilial activity and make expectoration difficult. Humidification will solve these problems.
Humidification of oxygen
There are two methods of humidification: inhalation of water vapour and inhalation of nebulized particles26. Heated water vapour has been shown to be preferable to aerosol humiditv for maintenance of PaO2. This method is described below.
Nasal cannulae
Oxygen delivered by nasal cannulae has low flow rates (up to 6 L) and can be humidified by a cold water bubble humidifier (e.g. Respiflo, Hampshire, UK). This system is appropriate for use in hospital, with a concentrator and with nasal intermittent positive pressure ventilation to humidify the oxygen supply into the nasal mask. A bubble humidifier should never be attached to the oxygen inlet of a fixed concentration mask. The back pressure created by the air entrainment will cut off the oxygen supply.
24% and 28% fixed concentration masks A heated humidifier (e.g. Aerodyne, Fisher & Paykel, Hampshire, UK) is necessary to humidify the large volumes of gas delivered by 24% and 28% concentration masks and a high flow generator because the time interval for moisture transfer decreases as flow rate increases above 20 L/min. Humidification of the large volumes of gas is achieved by the gas flowing through the vapour of heated water. For humidification of 28% oxygen ( Figure 3 ) the oxygen concentration is selected on the Venturi adaptor of the heated column and the oxygen flow rate adjusted to 5 L/min or more according to patient comfort. The humidified gas mixture is delivered by wide bore tubing and an aerosol mask. Humidified 24% oxygen cannot be delivered in this way (Figure 4) . The oxygen is supplied by a 24% concentration mask and oxygen source. Humidification is provided from a heated air source and delivered to the oxygen mask by wide bore tubing attached to a humidity adaptor which surrounds the air entrainment holes of the mask. The oxygen flow rate is adjusted to the patient's comfort (2 L/min or more) and the total gas flow of the humidified air is matched to the flow of air entrained by the oxygen mask, by careful adjustment of the flow rate of the air supply and Venturi adaptor of the heater (Figure 4) The system is set up as Figure 2 . The oxygen supply line is fitted directly into the piped oxygen source. The flow rate is adjusted to the patient's comfort and the inspired oxygen concentration determined by flow alterations monitored with an oxygen analyser.
DOMICILIARY OXYGEN
Domiciliary oxygen is supplied for intermittent use to relieve symptoms, long-term use to reduce pulmonary hypertension and portable use to improve mobility. The different systems vary considerably in output and may not meet the needs required (Table 3) .
Intermittent use
Initially oxygen is usually prescribed for the relief of breathlessness and for short periods. F size cylinders with a capacity of 1360 L are prescribed by the general practitioner (GP) and supplied by the local pharmacist. For the purpose of safety the flow supply is limited to 2 and 4 L/min, and although the cylinder has the same pressure characteristics as the hospital source, the flow supply is limited. The GP can prescribe nasal cannulae and a 28% (but not 24%) concentration mask. The total gas flow is therefore limited with a 28% mask (44 L/min; Table 1 ) because the flow rate from the cylinder is limited to 4 L/min. Higher total flows can be achieved with a 24% mask (100 L/min) but this will have to be supplied by hospital care. Sometimes breathlessness may only be relieved by the high flow rates of a 24% mask at the expense of a lower PaO2 but the patient will feel more comfortable.
Long term use If more than four cylinders a week are needed it becomes more economical to prescribe an oxygen concentrator. To provide long-term oxygen therapy with cylinders was four times more expensive (L5000) than with a concentrator in 198627. Since that time, the cost differentials will have increased. The concentrator is prescribed by the GP in England and Wales (in Scotland by a physician), supplied by Devilbiss (Heston, UK), but fitted and serviced in the home by engineers. There are advantages and disadvantages to this form of supply. The obvious advantages are that the oxygen never runs out and there are no delivery or storage problems. The oxygen is made by removing nitrogen from room air so the oxygen is at room temperature and humidity. The disadvantages are the limited flow and pressure characteristics i.e. a flow of 5 L/min and a pressure of 8.5-13 PSI. This limited flow rate is only guaranteed with a maximum of 50 feet of tubing. The concentrator can be used with a 28% mask with a short length of tubing28 but the driving pressure may not be sufficient for a 24% mask. For our patients, with high inspiratory flow rates, a concentrator will not relieve breathlessness unless more than one are used in parallel to increase flow rates. It is important to appreciate that the oxygen is not 100% but 95-92% at 1-3 L flow and 80% at 4 L flow. The difference in these values may prove critical when the patient is ventilated at home with nasal intermittent positive pressure ventilation. An alternative to a concentrator is liquid oxygen. There are many advantages to this form of supply but it is expensive and not available on prescription. The advantages include a higher flow rate up to 10 L and a higher driving pressure 30 PSI. A stationary tank holds 30-45 L of oxygen which is equivalent to 25 200-37 700 L of gas. The major advantage is the portable unit which can be filled from the large unit (vide infra). The large cylinder will last 8-12 days with continuous use at 2 L/min. The suppliers in the UK are BOC Ltd (Surrey, UK), who provide the education and delivery service. The local District Health Authority should be approached for additional funding if domiciliary oxygen is inadequate.
Portable cylinders
Portable cylinders vary considerably in their characteristics and availability on prescription (see Table 3 ). The PD 300 with a capacity of 300 L is the only cylinder available on prescription. It is obtrusive, heavy and cumbersome ( Figure  5 ). It has a short duration (2.5 h at 2 L/min) and is replaced at the pharmacy when empty. Smaller cylinders (240 L) can be purchased and filled from an F size cylinder in the home. Decanting of gases is hazardous, the cylinder can only be completely filled if the F cylinder is full so the duration is often less than 2 h. The design of the portable unit of liquid oxygen is less obtrusive, easier to carry and has a duration of [8] [9] [10] h. This allows the patient greater Life Support, Bedfordshire, UK (Figure 6 ), Sabre, Hampshire, UK]. The Oxylite system uses lightweight aluminium cylinders reinforced with resin bonded fibres (filled from an F size cylinder in the home) with a small electronic battery operated conserver (Oxymatic). The conserver electronically senses end-expiration and the beginning of inspiration and delivers a pulse of 35 Figure 6 Oxylite system of light weight cylinders and electronic oxygen conserver (Life Support (Europe) Ltd, Bedfordshire, UK) this problem but this is obviously not recommended when one of the aims of ambulatory oxygen is to decrease breathlessness. Alveolar ventilation occurs early in inspiration, during one-sixth of the respiratory cycle; delivery over 0.2 s at 16 breaths per minute will provide oxygen for onenineteenth of that cycle. Others have found this system to be inferior to continuous flow oxygen during exercise30. However, the cylinders are lightweight and easily carried.
Perhaps the system could be improved with the delivery of a larger volume than 35 ml or longer duration than 0.2 s. Careful assessment is required at rest and during exercise before recommending this system. It is clear that very careful assessment of oxygen requirement is needed to meet the varying demands and match available systems. This evaluation usually takes place in the hospital setting with recommendations to the general practitioner for prescription. The supplier of this prescription is the local pharmacist or engineer of the concentrator manufacturer. Detailed written recommendations are necessary by all parties to prevent the potential for error. The patient usually follows the advice of the last person in the chain, i.e. pharmacist or engineer! TRAVEL Travel at home and abroad is no longer a luxury but part of a normal life both in health and disease. Our patients are no exception to that premise. More patients are travelling abroad and physicians are increasingly being asked to provide confirmation of 'fitness to fly' by both insurance companies and airlines. Issues surrounding travel abroad include assessment of induced oxygen desaturation during flight, the amount of oxygen for the duration of the flight and the supply of oxygen at the destination. The outside air used for air conditioning is very cold and has a relative humidity of 1%. This is increased by the moisture of the expired air of passengers and crew, and moisture from the galleys and toilets. However, it still remains between 10% and 12% which is well below the accepted comfort level of 20%36. Flight and cabin crew are advised to maintain an adequate fluid intake; this has particular relevance in CF and regular oral hydration (not alcohol or carbonated drinks) for all patients is extremely important.
Airlines do not supply 02 for ground use so changing flights is best avoided. They may not supply both masks and nasal cannulae so these details need to be determined. Although both venturi masks and nasal cannulae relieve hypoxaemia, it has been shown that only nasal cannulae restored PaO2 to baseline levels in patients with chronic obstructive pulmonary disease37. Airlines are not legally obliged to manage specific medical needs or indeed accept all patients. The request for in-flight oxygen is submitted with the flight reservation using the INCAD form38. It is provided by the travel agent and completed by the attending physician. It is crucial to plan any journey well in advance, to understand the airline's in-flight policy and confirm availability of oxygen in writing.
Oxygen supply at destination
An oxygen concentrator can be taken abroad and usually at no extra cost. The company must be informed, the concentrator insured and clearance agreed by the airline. It is advisable to determine the address of a local chemist for back-up cylinders in case of breakdown. Airlines may allow passengers to carry small cylinders but confirmation is needed from the airport authority. Information guidelines and advice is available from around the world for patients with pulmonary disease38-39. The Embassy of the visiting country will often supply addresses of oxygen suppliers. Devilbiss Health Care (Heston, UK) can also supply information and can arrange rental of equipment39. Prices will vary so it is worth asking for written quotations because oxygen can be a considerable financial extra to the holiday.
Travel in the UK Again, a concentrator can be transported in an upright position and the company informed of the destination address in case of breakdown. If cylinders are carried in the car it is advisable to inform the insurance company and check with the pharmacist the position of storage. Bus companies and rail operators are usually agreeable to the use of oxygen on public transport but it is wise to check well in advance. Coach firms are not allowed to carry oxygen cylinders due to EC directives but may carry a concentrator. CONCLUSION The practical application of oxygen therapy in CF is complex. We need to optimize oxygen delivery to the CF patients at home and in hospital. Each patient will require meticulous evaluation and detailed specific prescription to match lifestyle and severity of lung disease. 'Getting it right' will improve both the patient's quality of life and clinical outcome.
